Tensioline
Food supplement declared in France, declaration No 2018-8-869
Tensioline is a food supplement declared in France. Status: retiré du marché le 30 June 2024. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- LUBERON TECHNOLOGIES LABO (LT LABO ORGANOSILICES.LT LABO ELIXIRS) (LTLO LTELF LTLSVN)
- Status
- Retiré du marché le 30 June 2024
- Form
- Gélule
- Daily dose
- 3
- Directions for use
- 2 à 3 gélules par jour, avec un verre d’eau.
- Not recommended for (according to the manufacturer)
- Femmes enceintes, Sous anticoagulants, Utilisation prolongée
Declaration 153100, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Psidium guajava L.: Seule l'utilisation des extraits aqueux et alcooliques de titre faible (25% v/v) est autorisée
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Retiré du marché le 30 June 2024, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Hieracium pilosella L. | Parties aériennes | Poudre (de plantes séchées ou broyées) | 600 mg |
| Olea europaea subsp. europaea | Feuille | Extrait sec aqueux | 450 mg |
| Allium sativum L. | Bulbe | Extrait sec hydroalcoolique | 150 mg |
| Psidium guajava L. | Fruit | Extrait sec aqueux | 8.1 mg |
| Ocimum tenuiflorum L. | Feuille | Extrait sec aqueux | 2.7 mg |
| Citrus limon (L.) Burm. f. | Fruit (écorce) | Extrait sec aqueux | 2.7 mg |
Additives
Hydroxypropyl Méthyl Cellulose
Other ingredients
Extrait de riz, Gélule végétale, Concentré de riz
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
NE PEUT REMPLACER une alimentation variée et équilibrée et un mode de vie sain. Tenir hors de portée des jeunes enfants. ne pas dépasser la dose conseillée. Déconseillé aux personnes sous traitement anti-coagulant. Déconseillé chez la femme enceinte. Conserver à l'abri de la chaleur dans un endroit sec. utilisation prolongée déconseillée.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- TENSIOLINE LT LABO, declared in 2025 : different composition: 3 ingredient(s) added, 7 missing
- TENSIOLINE LT LABO, declared in 2024 : different composition: 1 ingredient(s) added, 7 missing
- TENSIOLINE LUBERON TECHNOLOGIES LABO (LT LABO ORGANOSILICES.LT LABO ELIXIRS) (LTLO LTELF LTLSVN), declared in 2021, withdrawn from the market : different composition: 2 ingredient(s) added, 7 missing